Accuracy supported dsm-firmenich by performing two-way financial due diligence and financial advisory services for the carve-out and sale to KD Pharma of the MEG-3 fish oil business for the Food & Beverage, Dietary Supplement and Pharma markets, together with the production facilities in Piura, Peru, and Mulgrave, Canada.
Accuracy prepared a financial fact book and supported dsm-firmenich throughout the entire transaction process with valuation and SPA assistance. In addition, buy-side DD was performed on KD Pharma as dsm-firmenich obtained a minority stake of 29% in KD Pharma’s parent company, O³ Holding, in exchange for the MEG-3 business.